Jonathan Burlison, Ph.D., is the Patient Safety Project manager in the Pharmaceutical Sciences Department at St. Jude Children’s Research Hospital.
Researchers at St. Jude explain what immunity is and how it works.
Platform Design, a software package, enables clinicians to add study arms to a clinical trial.
The ADAPT study revealed barriers that stand in the way of palliative care in Latin America.
Research reveals how inherited genetic variants can contribute to liver toxicity after chemotherapy.
Learn how Daniel Blair, PhD, is creating a laboratory research culture based on sincerity, kindness and the curiosity to ask pressing scientific questions.
This International Childhood Cancer Day St. Jude Global shines a spotlight on the Global Initiative collaboration with WHO.
St. Jude is at the forefront of creating tools to visualize and analyze genomic data.
St. Jude scientists are fueling progress by studying the molecular groups of different cancers.
The St. Jude HPV Cancer Prevention Program and the University of Memphis created Tigers VAX Now, a student ambassador program to empower college students to advocate for HPV vaccination as cancer prevention among their peers.
Scientists at St. Jude are leading the way on understanding cancer predisposition and the way that inherited genetics can inform patient care.